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ABSTRACT
Excessive alcohol intake can alter the gut microbiota, which may underlie the pathophysiology of
alcohol-related diseases. We examined gut microbiota composition and functions in patients with
alcohol overconsumption for >10 years, compared to a control group of patients with a history of
no or low alcohol intake. Faecal microbiota composition was assessed by 16S rRNA sequencing. Gut
microbiota functions were evaluated by quantification of short-chain fatty acids (SCFAs) and
predictive metagenome profiling (PICRUSt). Twenty-four patients, mean age 64.8 years (19 males),
with alcohol overconsumption, and 18 control patients, mean age 58.2 years (14 males) were
included. The two groups were comparable regarding basic clinical variables. Nutritional assessment
revealed lower total score on the screening tool Mini Nutritional Assessment, lower muscle mass as
assessed by handgrip strength, and lower plasma vitamin C levels in the alcohol overconsumption
group. Bacteria from phylum Proteobacteria were found in higher relative abundance, while bacteria
from genus Faecalibacterium were found in lower relative abundance in the group of alcohol
overconsumers. The group also had higher levels of the genera Sutterella, Holdemania and
Clostridium, and lower concentration and percentage of butyric acid. When applying PICRUSt to
predict the metagenomic composition, we found that genes related to invasion of epithelial cells
were more common in the group of alcohol overconsumers. We conclude that gut microbiota
composition and functions in patients with alcohol overconsumption differ from patients with low
consumption of alcohol, and seem to be skewed into a putative pro-inflammatory direction.
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Chronic alcohol overconsumption is an important
cause of impaired health, 1 and changes in gut micro-
biota have been suggested as a key factor in the devel-
opment of alcohol-related morbidity.2,3 However, as
pointed out in a recent review by Hillemacher et al., 4
clinical studies of gutmicrobiota in alcohol-dependent
humans have hitherto been sparse.
The gut microbiota may be evaluated either by
assessing its composition or by measuring its func-
tions. The composition seems to be host-specific,
develops from birth and throughout the lifespan, 5
and is affected by external factors like diet, surgery
and the use of antibiotics.6 Alcohol consumption
may also influence the composition, 7 consequently
affecting gut microbiota functions. Assessing micro-
bial metabolites, such as short-chain fatty acids
(SCFAs), may offer a way to evaluate such func-
tions. SCFAs are products of fermentation of unab-
sorbed food residues (mainly carbohydrates) within
the colon, and around 95% of the SCFAs are
absorbed and used as an energy source for the
host.8 SCFAs may also play an important role in
the communication between the gut microbiota and
other parts of the body.8–10 Although the excretion
of SCFAs is complex, the production seems to be
regulated and is dependent on bacteria.8 Thus,
assessment of SCFAs is a recognized measure of
gut microbiota function.
Using 13C-D-xylose breath tests, our group has
previously demonstrated differences between patients
with high and low alcohol consumption, findings that
suggest small intestinal malabsorption and alterations
of colonic microbiota as a consequence of alcohol
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overconsumption.11 In the present study, we aimed to
explore these observations further, by investigating
gut microbiota composition and functions in subjects
with chronic alcohol overconsumption.
Results
Participants
Data were available from 24 patients with chronic
alcohol overconsumption and 18 patients in the con-
trol group. The groups were similar regarding age and
gender (Table 1). We found no significant difference
in pancreatic, renal or hepatic function tests as
assessed by faecal or blood samples. The group of
active alcohol overconsumers had an average alcohol
consumption of 118.9 g/day, versus 2.5 g/day in the
control group. All control patients and half of the
patients in the group of alcohol overconsumers were
included during Hospital admittance. The rest were
included from the substance abuse-project accounted
for in the Patients and Methods section. The main
reasons for patients not being eligible for inclusion
from this group are summarized in Figure 1. Among
patients included during Hospital admittance, the
most common diagnoses or symptoms leading to
admittance were atrial fibrillation, transitory ischemic
attack and chest pain. Twenty-six patients (11 alcohol
overconsumers and 15 control patients) were initially
included in the study, but had to be excluded due to
lack of faecal sample.
There was no significant difference between the
groups regarding weight, height, BMI, muscle mass
or body fat (Table 1). Low muscle mass index was
common in both groups (91 vs 78%), while hand-
grip strength was significantly lower among alcohol
overconsumers. This group scored significantly
lower on the MNA test compared to the control
group. Sub-scores for “reduced appetite,” “few daily
meals” and “depression” were the main reasons for
the higher MNA scores in the control group (data
not shown). Alcohol overconsumers had signifi-
cantly lower levels of vitamin C, magnesium and
sodium, and higher MCV compared to the control
group (Table 1). Vitamin C deficiency defined as
plasma level <30 µmol/L, was found exclusively in
the group of patients with alcohol overconsumption
(30%), while one patient in this group had vitamin
A deficiency (<0.7 µmol/L). Vitamin B supplements
were frequently used, and deficiency of thiamine
(<70 nmol/L), folate (<6 nmol/L) or B12
(<160 pmol/L) was not present. Vitamin
D deficiency defined as 25(OH) Vitamin D< 50
nmol/L was present among 44%, and there were
no differences between the groups.
The use of medication, such as beta-blockers,
statins, and acetyl salicylic acid was similar in
the two groups. A higher proportion of alcohol
overconsumers were treated with proton pump
inhibitors (8, versus 2 in the control group).
However, we found no difference in abundance
of Proteobacteria, Holdemania, Clostridium,
Table 1. Baseline characteristics and nutritional screening results for patients with ongoing alcohol overconsumption (n = 24) and
control patients (n = 18).
Alcohol overconsumers Control Group
Variable (n = 24) (n = 18) P-value
Male n (%) 19 (79) 14 (77)
Age (years) mean (range) 64.8 (43–85) 58.2 (34–78) 0.076
BMI (kg/m2) mean (SD) 27.0 (4.4) 28.4 (4.0) 0.232
Muscle mass (kg) mean (SD) 26.3 (5.9) 27.2 (5.5) 0.614
Handgrip strength (kg) mean (SD) 29.8 (10.8) 38.1 (10.4) 0.019
Alcohol intake (g/day) mean (SD) 118.9 (93.4) 2.5 (2.9) <0.001
Vitamin A (μmol/L) mean (SD) 2.4 (1.0) 2.3 (0.4) 0.729
Vitamin B1 (nmol/L) mean (SD) 183.1 (66.5) 158.8 (30.9) 0.139
Folate (nmol/L) mean (SD) 23.5 (10.9) 19.8 (6.2) 0.176
Vitamin B12 (pmol/L) mean (SD) 458.0 (286.3) 473.7 (250.7) 0.854
Vitamin C (µmol/L) mean (SD) 38.9 (22.7) 60.7 (20.1) 0.004
Vitamin D (nmol/L) mean (SD) 50.6 (26.3) 55.2 (23.4) 0.568
MNA 1 (total score) mean (SD) 24.3 (3.3) 26.9 (2.4) 0.006
Sodium (mmol/L) mean (SD) 137.8 (4.9) 141.4 (1.7) 0.002
Magnesium (mmol/L) mean (SD) 0.78 (0.2) 0.86 (0.1) 0.029
MCV (fL) mean (SD) 98.5 (7.2) 90.9 (3.4) <0.001
Pancreas insufficiency2 n (%) 2 (11) 3 (12.5) 1.000
1MNA: Mini Nutritional Assessment. 2Patients with fecal elastase <200 μg elastase/g feces.
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Faecalibacterium or Sutterella, when comparing
patients with proton pump inhibitors, to those
without.
Sequencing, mapping, and counting of gut
microbiota composition
After sequence read filtering, 64000 reads per sam-
ple were obtained and used for operational taxo-
nomic unit (OTU) construction. The sequencing
depths achieved were sufficient to evaluate the
bacterial diversity in all samples, as evaluated by
rarefaction plots (data not shown).
Using the Shannon alpha-diversity measure-
ment, we found no average difference between
alcohol overconsumers and control patients
(Shannon median score 5.81 and 5.74 for controls
and alcohol overconsumers).
Using UniFrac values calculated from the nor-
malized OTU count table, we found no trends
using the weighted algorithm. However, the quali-
tative approach identified a sub-cohort of alcohol
overconsumers with a different microbiome
composition than control patients. In addition,
testing for differences between groups showed sig-
nificant differences both using the weighted (p =
0.003, Tukey’s HSD test) and unweighted (p =
0.002, Tukey’s HSD test) algorithm.
Relative abundance analysis
We focused our analyses of bacterial taxa abundance
on relative abundance at the phyla and genus
level. At the phylum level, four phyla dominated
(Figure 2(a)). Testing for differential abundance at
phylum level showed that alcohol overconsumers
had a significantly higher relative abundance
of Proteobacteria (Figure 2(b), median value
0.02 (IQR 0.021) and 0.009 (IQR 0.018),
p = 0.013, Mann–Whitney U-test). We found no sig-
nificant difference among the other phyla present
(Firmicutes, Bacteroidetes, Actinobacteria). We found
no dose-dependent relationship between the amount
of alcohol consumption and Proteobacteria.
Firmicutes: Bacteroidetes ratio was similar in
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Figure 1. Flow chart of inclusion process.
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the groups (median 0.88 and 0.81, respectively;
p = 0.22, Mann-Whitney U test).
Testing for differential abundance at the genus
level (including genera with an average relative abun-
dance >0.001) we found a lower relative abundance of
Faecalibacterium in the group of alcohol overconsu-
mers, and a higher relative abundance of Sutterella,
Clostridium, and Holdemania (Figure 3(a–d), Mann–
Whitney U test).We found no significant correlations
between the amount of alcohol consumption and
these genera.
As a complementary and validating method to
identify differentially expressed taxa, we applied
linear discriminant analysis effect size (LEfSe)12
(Figure 4(a)). First, we generated a bar plot of the
effect size of taxa with differential relative abun-
dance between alcohol overconsumers and controls
(Figure 4(a)). Of note, we found that the effect size
was large for phylum Proteobacteria, and all genera
previously found to have a different relative level
were also identified in this test. However, this strat-
egy yielded additional candidates with different
levels of abundance, including Ruminococcaceae
and Prevotella (higher in controls). Secondly, we
generated a cladogram to illustrate the relationship
between different taxa (Figure 4(b)). This figure
also shows a higher relative abundance of
Proteobacteria, and illustrated that this difference
was partly due to the families Enterobactericaea
and Desulfovibrionaceae. We also observed a lower
relative abundance of several taxonomic groups
within the Firmicutes phylum, in particular the
class Clostridia. Furthermore, in this test
Actinobacteria was also found to be at the lower
Figure 2. Relative bacterial composition at the phylum level. (a) Pie charts depicting the average relative abundance for major phyla for
alcohol overconsumers (n = 24) and controls (n = 18). (b) Relative abundance of Proteobacteria for alcohol overconsumers (n = 24) and
controls (n = 18). The lines represent median values.
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relative expression in alcohol overconsumers rela-
tive to controls.
Short-chain fatty acids (SCFAs)
For butyric acid, we found a lower percentage
(11.9% versus 16.3%, p = 0.012, Mann Whitney
U-test) and a tendency towards a lower concentra-
tion (3.9 mmol/kg vs 5.6 mmol/kg, p = 0.054, Mann
Whitney U-test) in faecal samples of alcohol over-
consumers, than in samples from the control
patients. Concentration and percentage of the
other SCFAs, and the total amount of SCFAs
were similar in the two groups (Table 2). In alcohol
overconsumers, Protebacterium abundance
correlated inversely with butyric acid levels
(Spearman`s rho = −0.61, p = 0.002), acetic acid
levels (Spearman`s rho = −0.48, p = 0.02), valeric
acid levels (Spearman`s rho = −0.45, p = 0.03) and
total amount of SCFAs (Spearman`s rho = −0.53,
p = 0.008). We found a positive correlation between
Faecalibacterium abundance and concentration of
butyric acid (Spearman`s rho = 0.4, p = 0.05), and
an inverse correlation with iso-butyric acid
(Spearman`s rho = −0.45, p = 0.03) and iso-
valeric acid (Spearman`s rho = −0.49, p = 0.014).
For Sutterella, Holdemania, and Clostridium, we
found no significant correlations with SCFAs.
Predictive metagenomic analysis
Using PICRUSt, we inferred the gene content of
the microbiota based on the 16S rRNA sequences
(Figure 4(c)). The inferred gene counts were
merged into larger categories (level 3 KEGG
orthology), based on their molecular function,
involvement in disease, metabolic pathways or
cellular function. Notably, we found that the gut
Figure 3. Differences in bacterial composition between alcohol overconsumers (n = 24) and controls (n = 18) at genus level. The
lines represent median values. (a) Faecalibacterium levels. (b) Clostridium levels. (c) Sutterella levels. (d) Holdemania levels.
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microbiota of patients with alcohol overcon-
sumption had relatively more bacteria containing
genes for “Bacterial invasion of epithelial cells”.
A closer inspection revealed that a subset of these
patients had very high counts (reaching up to
>4500 reads), while none of the controls had
a read count >350 (median 85). The observed
difference was almost entirely determined by
Figure 4. Cross-taxa validation and functional characterization of gut microbiota in alcohol overconsumers (n = 24) and controls (n =
18), where green color indicates taxa enriched (↑) in alcohol overconsumers, and red color indicates taxa depleted (↓) in alcohol
overconsumers. (a) Taxa with statistical different relative levels between alcohol overconsumers (n = 24) and controls (n = 18), with
effect size, across all taxa. (b) Cladogram showing phylogenetic relationships between taxa that are statistically different. (c) Barchart
with KEGG orthology functional terms identified by PICRUSt as different in alcohol overconsumers (n = 24) and controls (n = 18).
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higher levels of genes in the adhesion/invasion
gene category (K13735).
Discussion
Diversity analyses indicated a difference in gut micro-
biota composition between patients with chronic alco-
hol overconsumption and controlswith a history of no
or low alcohol intake. At phylum level, patients with
alcohol overconsumption had a higher relative abun-
dance of Proteobacteria. They had a lower relative
abundance of genus Faecalibacterium, and a higher
relative abundance of the genera Clostridium,
Sutterella and Holdemania. We found lower percen-
tages and concentrations of butyric acid in alcohol
overconsumers, while other SCFA-levels were similar
in the groups.
Our results suggest that alcohol contributes to
over-representation of Proteobacteria in the gut, con-
sistent with previous studies on humans 2 and
rodents.13 Proteobacteria seem to play an important
role in the development of disease related to the gut
microbiota.14 They are endotoxin (lipopolysacchar-
ide, LPS) containing, Gram-negative, facultative
anaerobic rods. Among the quantitatively dominant
phyla that comprise the gut microbiota,
Proteobacteria is the most unstable over time, and
some researchers have proposed it as a biomarker
for dysbiosis.14 In addition to serve as markers, they
also possibly play a role in the development of diseases
where a pro-inflammatory activation of the immune
system in the intestines is vital for the
pathophysiology.14,15
A high relative abundance of genus
Faecalibacterium like Faecalibacterium prausnitzii is
generally believed to be protective against gastroin-
testinal, 16 as well as extra-intestinal conditions.17 In
our study, the group of alcohol overconsumers had
a lower relative abundance of bacteria from genus
Faecalibacterium than the control patients did, con-
sistent with previous studies.18 Together with the
increased relative abundance of Proteobacteria, this
indicates a potentially more inflammatory active gut
microbiota within this group.
We found higher relative abundance of genera
Sutterella (Proteobacteria), Holdemania and
Clostridium (both Firmicutes) in alcohol overcon-
sumers. Previous studies have concluded that
Sutterella species are possible pro-inflammatory
agents.19 Leclerq et al. discovered decreasing
amounts of Holdemania and Clostridium (patients
with high intestinal permeability) after three weeks
of sobriety in patients with previous alcohol
overconsumption.20 Species from these genera
may play a role in the pathophysiological develop-
ment of other medical conditions, but this is pre-
sently unclear.
We found a lower percentage, and a tendency
towards a lower concentration of butyric acid, in
the feces of alcohol overconsumers. The concentra-
tions and fractions of the other quantified SCFAs,
and the total amount of SCFAs, were similar in the
two groups. Further analyses revealed an inverse
relation between Proteobacteria abundance, and
concentrations of butyric acid, acetic acid, and the
total amount of SCFAs. We also discovered
a positive correlation between Faecalibacterium,
and butyric acid levels. The composition of the
gut microbiota is central for which SCFAs that are
formed, and in which amount. SCFAs in general
and butyric acid in particular, are important factors
for the gut homeostasis, including the maintenance
of the intestinal wall integrity.21,22 The formation of
Table 2. Concentrations of short chain fatty acids (SCFAs),
measured in mmol/kg (median, min – max) and percentage







(n = 18) P-value
Acetic acid 17.6 (6.8–44.2) 23.0 (13.8–49.0) 0.113
% of total SCFA
concentration
60.3 (44.7–73.0) 60.4 (49.3–74.8) 0.811
Propionic acid 4.9 (1.7–18.9) 6.6 (2.0–14.3) 0.678
% of total SCFA
concentration
15.7 (10.0–35.4) 15.0 (4.1–26.0) 0.442
Iso-butyric acid 0.6 (0.2–3.5) 0.8 (0.14–3.3) 0.166
% of total SCFA
concentration
2.3 (0.6–4.9) 2.1 (0.2–4.6) 0.831
Butyric acid 4.1 (1.2–24.8) 5.6 (3.3–20.6) 0.054
% of total SCFA
concentration
12.1 (6.9–27.9) 16.3 (11.5–22.4) 0.012*
Iso-valeric acid 0.7 (0.25–5.0) 1.0 (0.1–4.8) 0.253
% of total SCFA
concentration
2.8 (0.4–7.1) 2.7 (0.2–6.8) 0.753
Valeric acid 0.9 (0.0–4.5) 0.96 (0.0–4.4) 0.965
% of total SCFA
concentration
3.1 (0.0–10.1) 2.4 (0.1–6.4) 0.307
Iso-capronic acid 0.0 (0–0) 0.0 (0.0–0.08) 0.429
% of total SCFA
concentration
0.0 (0–0) 0.00 (0.0–0.16) 0.429
Capronic acid 0.1 (0.0–1.6) 0.13 (0.0–1.1) 0.831
% of total SCFA
concentration
0.14 (0.0–1.6) 0.2 (0.0–1.1) 0.609
Total SCFA (mmol/kg) 32.7 (11.1–93.5) 37.7 (20.7–92.1) 0.168
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butyric acid within the colon partly depends on
species from the phylum Firmicutes, such as
Faecalibacterium prausnitzii.21 A high level of buty-
ric acid is considered to be protective against the
inflammatory activity, 23 and low levels of this
SCFA has been related to conditions such as
Crohn’s disease.24 The impact of alcohol use on
SCFA formation has been studied far more exten-
sively in rodents than in humans. Xie et al. discov-
ered that feeding with alcohol led to a decreased
level of butyric acid in rats.25 In a study in mice,
butyrate supplementation protected against injur-
ious effects of alcohol intake, on tight junctions
and the liver.26 In the light of this, the difference
in butyric acid between the groups, and the rela-
tions between SCFAs and bacterial taxa, are intri-
guing. These findings may represent a possible
physiological link between gut microbiota composi-
tion, and the harmful effects from alcohol over-
consumption. However, due to the complexity of
SCFA formation and its interplay with gut micro-
biota and the intestinal epithelium, these results
must be interpreted cautiously, especially within
the limits of a cross-sectional study design.
Predictive metagenome profiling may be used to
evaluate inferred functional aspects of
microbiomes.27 Using PICRUSt, our study demon-
strated several differences in such variables that
may be of pathophysiological significance, but the
findings are challenging to interpret and should be
considered with caution. However, in the light of
microbial differences pointing in a putative pro-
inflammatory direction, the observed prevalence of
genes related to bacterial invasion of epithelial cells
is an intriguing functional culprit, possibly brid-
ging microbial compositional differences and
immunological consequences. In this scenario,
the ability of bacteria to invade an epithelial cell
and immune ‘sensing’ of potentially harmful bac-
teria may trigger an immune response, potentially
associated with anxiety and depression.10
However, in order to examine this further, we
would need to perform functional analyses on the
study subjects.
When evaluating nutritional aspects, we prioritized
screening in terms of function instead of quantifying
food-intake, such as using food frequency question-
naires. By examining anthropometric measures
including several markers for sarcopenia, quantifying
vitamins and minerals, and using the screening tool
MNA, we got an overview of the patients` overall
nutritional risk. We found that the alcohol overcon-
sumers had lower vitamin C-levels, sarcopenia as
assessed by handgrip strength, and a lower overall
MNA-score. Other biochemical and sarcopenia mar-
kers were similar in the two groups. Overall, the group
of alcohol overconsumers seemed to have certain
signs of an inadequate nutritional intake, and we
cannot rule out that this is a factor in explaining
parts of the microbiota-findings.
Strengths and limitations
The impact of long-term excessive alcohol inges-
tion on gut microbiota composition and functions
has been sparsely studied in man, and the inclu-
sion of a representative control group from the
same clinical population as the cases, rather than
recruiting healthy volunteers, is a unique feature of
our study. The relatively small sample size, the lack
of detailed information regarding dietary intake
that might affect levels of bacteria and SCFAs,
and detailed information regarding organ disease
(although no patients with severe organ failures
were included) that potentially might affect the
gut microbiota, represent limitations of the study.
Moreover, the choice of a cross-sectional design
reduces the possibility of drawing causative con-
clusions. We also acknowledge that the recall-
dependent method applied for quantification of
alcohol use is a potential source of error.
Conclusion
In conclusion, there seems to be an association
between chronic alcohol overconsumption, and
certain compositional and functional character-
istics of the gut microbiota, which in alcohol
overconsumers are skewed into a putative pro-
inflammatory direction. The clinical impact and
causal relation between alcohol use and these
alterations should be investigated further, in the
form of controlled experiments and longitudi-
nal studies.
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Patients and methods
Participants
We recruited patients from Lovisenberg Diaconal
Hospital during two time periods (Figure 1). First,
from 2011 to 2013, a project was carried out at our
hospital aiming to identify patients with poten-
tially health-threatening substance abuse, for sub-
sequent follow up after discharge (n = 355). The
majority of this cohort of consecutively included
patients had chronic alcohol overconsumption (n
= 351; 259 males), and they were hence eligible for
inclusion in the present study. Secondly, we asked
consecutive patients admitted to the hospital dur-
ing the inclusion period from September to
December in 2014 to participate (n = 32; 24
males). The inclusion criteria were an ongoing or
recent history of alcohol overconsumption of more
than 20 or 40 g of alcohol per day for women and
men.28–30 Exclusion criteria were conditions or
treatments with a suspected influence on the gut
microbiota. This included a history of abdominal
surgery (except appendectomy), inflammatory
bowel disease, gastrointestinal cancer, infectious
gastroenteritis (last four weeks), or an ongoing or
recent use of antibiotics (last four weeks). Patients
with severe organ failure(s) or cognitive impair-
ment were not included. From September to
December 2014, we also contacted the patients in
the substance abuse-project via telephone calls for
inclusion, making two attempts to reach each
patient: once during daytime and once in the after-
noon. In this patient group, all parts of the study
were conducted via the hospital outpatient clinic.
In the group of admitted patients, all parts of the
study were conducted during their stay at the
hospital. A control group was recruited from con-
secutive patients admitted to the hospital from
September to December 2014, with no history of
alcohol overconsumption. This was specified as
a present daily intake of less than 5 or 10 g per day
for women or men, no history of intake of more
than 20 g per day for longer periods, no history of
prolonged binge drinking, and no history of daily
alcohol intake. Regarding all patients, a faecal sam-
ple was required for inclusion in the present study.
The study was approved by the Regional
Committee for Medical Research Ethics (REK
Sør-Øst; reference number 2013/2357), and
conducted according to the Declaration of
Helsinki. We obtained a written informed consent
from all study participants.
Assessment of alcohol intake and nutritional
status
We applied “Time line follow-back”31 to assess the
amount of alcohol intake. The instrument was used to
capture daily alcohol use (unit for unit) for a period
between 2 and 4 previous weeks. These data were
applied as a basis for alcohol use over time, in accor-
dance with the patients’ recollection of alcohol intake
prior to this 2–4week period. The patients’ nutritional
status was evaluated using the screening tool Mini
Nutritional Assessment (MNA)32 and anthropo-
metric measures (height, weight). Muscle mass was
assessed by a Tanita BC-418 Segmental Body
Composition Analyzer (TANITA Corporation,
Tokyo, Japan). As a marker for muscle function, we
measured the participants’ handgrip strength by
a dynamometer (Kern MAP, Kern & Sohn,
Balingen, Germany). Biochemical markers included
vitamins A, B1, B9, B12, C and D, hepatic and renal
function tests, hematological status, iron levels, and
electrolytes, and were measured as part of the hospi-
tal’s routine analyses. Fecal levels of elastase were
measured using a commercial kit (Human
Pancreatic Elastase ELISA BS 86–01, Bioserv
Diagnostics, Rostock, Germany). Based on elastase
levels, patients were classified as having a normal
exocrine pancreatic function (>200 μg elastase/g
feces), moderate exocrine pancreatic insufficiency
(100–200 μg elastase/g feces), or severe exocrine pan-
creatic insufficiency (<100 μg elastase/g feces).
Analysis of gut microbiota composition
Faecal samples were collected in empty plastic
tubes (Sarstedt AG & Co, Nümbrecht, Germany),
immediately frozen at minus 20°C, and transferred
to minus 80°C within one week. Isolation of DNA,
DNA sequencing and initial bioinformatics ana-
lyses were performed by Novogene (Beijing,
China). Total genomic DNA was extracted using
the CTAB/SDS method. DNA concentration and
purity was measured on 1% agarose gels before
DNA was diluted to 1 ng/μL with sterile water.
All PCR reactions were carried out with Phusion®
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High-Fidelity PCR Master Mix (New England
Biolabs, Ipswich, USA). The 16S V3-V4 region
was amplified using 342F/806R as a primer set,
and the resulting amplicons were visualized using
SYBR green on a 2% agarose gel. Samples with
a band between 400 and 450 base pairs (bp) were
chosen for further experiments. Polymerase chain
reaction products were mixed in equimolar ratios.
Then, mixture PCR products were purified with
Qiagen Gel Extraction Kit (Qiagen, Germany).
Sequencing libraries were generated using
TruSeq® DNA PCR-Free Sample Preparation Kit
(Illumina, USA), and index codes were added. The
library quality was assessed on the Qubit@ 2.0
Fluorometer (Thermo Scientific) and Agilent
Bioanalyzer 2100 system. The libraries were
sequenced on an Illumina HiSeq 2500 platform
generating 250 bp-end reads.
Bioinformatics
After sequencing, bp-end reads were assigned to
samples based on their barcode sequence, and then
trimmed by cutting off the barcode and primer
sequence. Paired-end reads were merged using
FLASH (v1.2.7), 33 and the merged reads were qual-
ity filtered to obtain high-quality reads using QIIME
(V1.7.0).34 The merged reads were compared with
the gold reference database using the UCHIME
algorithm35 to detect and remove chimeric reads,
resulting in a set of effective reads. Using UPARSE
(v7.0.1001), 36 we merged sequences with ≥97%
similarity into the same Operational taxonomic
unit (OTU). Representative sequences from each
OTU were then used to annotate the OTUs using
the RDP classifier (v2.2) and the GreenGene
Database.37 OTU abundances were down-sampled
to the sample with the least sequences, and analysis
of alpha diversity and beta diversity were all per-
formed using this normalized dataset. Alpha diver-
sity was measured using Shannon metrics calculated
using QIIME (v1.7.0). Beta diversity analysis was
performed using both weighted and unweighted
UniFrac, calculated by QIIME. These distance
matrices were used for clustering in R (hclust).
Relative taxa abundances were obtained by dividing
the count for each taxa by the total number of reads
in their respective sample.
Analysis of short chain fatty acids (SCFAs)
We investigated faecal SCFA content using methods
previously described by Zijlstra et al., 38 and mod-
ified by Hoverstad et al.39 Briefly, faecal samples
were vacuum distilled, and subsequently, gas chro-
matography of the distillates, using flame ionization
detection, was used to quantify the SCFAs. We then
calculated concentrations and percentages of the
following SCFAs: acetic acid, propionic acid, iso-
butyric acid, butyric acid, iso-valeric acid, valeric
acid, iso-capronic acid, and capronic acid.
Predictive metagenomic analysis
To investigate possible functional differences between
patients and controls, we applied phylogenetic inves-
tigation of communities by reconstruction of unob-
served states (PICRUSt), a computational method to
predict the functional composition of a metagenome
using marker gene data, and a database of reference
genomes.27 PICRUSt predicts which gene families are
present and quantify them using the 16S data, based
on similarities between the large number of sequenced
bacterial genomes and those not sequenced. In the
present case, we used the obtained OTUs from
UPARSE as a marker gene, and re-annotated them
using BLAST with the GreenGene database. The
OTU count table was normalized against 16S copy
number before calculating metagenomic scores for
KEGG orthology (KO) terms.40 These were further
merged using the “categorize_by_function.py” script
(to level 3). The resulting terms approximate the
metagenomes of the patients, or in other words,
which genes that are present in the bacterial genomes
of the gut microbiota.
Statistical analyses
Data were analyzed using SPSS version 18.0.
Figures were made by using GraphPad Prism ver-
sion 8. P-values of <0.05 were set as a threshold for
statistical significance. Continuous, normally dis-
tributed data, including demographical data,
anthropometric data, and blood samples were ana-
lyzed using Student’s t-test. Mann Whitney U-test
was used to compare the test results of MNA and
SCFAs, all of which had a non-normal distribu-
tion. Fischer’s exact test was used to compare
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fractions of patients in danger of malnutrition
(MNA), and patients with pancreas insufficiency.
Differences in relative abundance at the phylum-
and genus level were compared using Mann
Whitney U-test, and operational taxonomic units
with a relative abundance of >0.001 (0.1%) were
considered relevant. Correlation analyses were
performed using Spearman`s rho correlation test.
Due to the explorative nature of our study, we did
not correct for multiple testing. However, we did
perform a complementary and validating addi-
tional test using linear discriminant analysis effect
size (LEfSe).12 Beta diversity was analyzed using
one-way ANOVA, followed by Tukey’s HSD test
for weighted (takes into account amount of the
different species) and unweighted (focuses only
on the presence of different species) analyses.
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